You can buy or sell argenx SE and other stocks, options, ETFs, and crypto commission-free!
argenx SE American Depositary Shares, also called argenx SE, is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. Read More The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands.
52 Week High
52 Week Low
— per share
Available May 14, Pre-Market